←
Crown Bioscience10,195 posts
Crown Bioscience avatar

Crown Bioscience

@crownbioscience

Crown Bioscience is a global contract research organization (CRO) dedicated to accelerating drug discovery and development in oncology and immuno-oncology.

◷ Joined June 2010▧ 7,137 Photos and videos
Crown Bioscience avatar
Crown Bioscience@crownbioscience·10h

For Santi Suryani Chen, PhD, what makes working in Crown Bioscience significant is the teamwork that goes on behind the scenes. Through logistics, finance, operations, procurement, and commercial, individuals ensure that every test article that arrives at Crown can succeed.

0:32
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 17

Ludovic Bourre discusses how the same features that make NAMs attractive - patient‑derived samples, defined mutations, and controlled microenvironments - also make them powerful engines for hypothesis‑driven biomarker discovery. Listen to the episode: okt.to/IRTbu7

0:57
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 16

CDK4/6 inhibitors have demonstrated the therapeutic potential of CDK inhibition in breast cancer. In our latest blog post, we explore why advancing these programs requires relevant preclinical models that reflect sensitivity and resistance mechanisms. okt.to/FhdOoa

Post attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 13

Over 7 years Bryan Miller has seen how close-knit the team is, which leads to faster problem-solving, sharper ideas, and natural collaboration. At Crown, we encourage our people to support one another, challenge current practices and grow as individuals.

0:22
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 12

Our latest research from SITC 2026 presents a fast, high-content screening platform to assess immunotherapy responses. Download the poster to explore comparative analyses of immunotherapy responses across patient-derived organoid co-culture models. okt.to/3ob7hd

Post attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 11

🎙️Crown Bioscience is working to accelerate the adoption of New Approach Methodologies (NAMs) across drug discovery and development. Our role in the @CPathInstitute NAMs Developer Coalition, will enhance oncology research. Listen to the full episode: okt.to/NHkyTK

1:06
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 10

Our IHC menu has a dedicated “Tumor Antigen / ADC Target” category, with markers like Claudin 18, B7H3, FOLR1, and Mesothelin ready to run on validated protocols. If you don't see your target, let us know and we can validate it for you: okt.to/nqDrCu

Post attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 9

In this on-demand webinar, see how integrated breast cancer model systems can support oncology drug discovery from early in vitro screening through in vivo efficacy studies and translational strategy. Watch the full video: okt.to/azZf6Q

0:56
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 9

Our team were delighted to be at SITC 2026, showcasing some of our latest preclinical and translational oncology data. You can view all of our scientific posters online and schedule a meeting with an expert to discuss your research needs: okt.to/hdGUJs

Post attachmentPost attachmentPost attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 6

Earlier today we announced we won the Drug Development Solution Award in the 2026 BioTech Breakthrough Awards! @John Gu, Chief Executive Officer and Chief Operating Officer commented on this achievement. Read the full announcement: okt.to/r8fmbs

Post attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 6

📣We have been honored with the Drug Development Solution Award in the 2026 BioTech Breakthrough Awards! The award recognizes our integrated antibody-drug conjugate (ADC) research and development platform. Read the full announcement: okt.to/lCxW2K

Post attachment
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 5

For Jessie Wang, working at Crown Bioscience means access to expertise, global perspectives, and a shared target. When people share ideas across disciplines, the work becomes sharper and more resilient. Helping our people develop as individuals strengthens our company.

0:23
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 4

3D organoid models better preserve tumor biology, including growth factor dependencies, opening new possibilities for screening beyond 2D systems. OrganoidXplore™ is an assay-ready service that processes up to 250+ models in as little as 6 weeks: okt.to/vbxqBj

0:44
Crown Bioscience avatar
Crown Bioscience@crownbioscience·Nov 2

📣We are delighted to announce the appointment of Guy Sheets as Senior Vice President, Commercial. Guy will lead Crown Bioscience’s global commercial strategy and drive growth. He has over 30 years of experience in the pharma and biotechnology industry. okt.to/RFUVuY

Post attachment